Speaker Biographies

BioMarin is a growing biotech firm with a strategic focus on treating rare diseases using first or best in class therapies. As the Global Head of Supply Chain, Robert Bottome is accountable for planning, logistics and GMP procurement. He has 23 years experience in BioPharma technical operations, and has also worked in semi-conductor and construction. For 16 years, he held a series of operational leadership roles at Roche-Genentech, including head of commercial and clinical packaging.

Evi is an experienced pharmaceutical executive with extensive background in developing global business portfolios with emphasis on new products, technologies, and IP. He is a skilled innovation management professional with experience managing global business process transformations and cross-functional teams. As Vice President, Global Life Sciences and Healthcare at Appian, Evi is responsible for client success and continued steady growth in license revenues across all pharmaceutical and healthcare clients. Formerly, VP Global Innovation at Catalent he established global innovation and IP strategies. He held prior roles in Legal Affairs, R&D, QA, Regulatory Affairs and Project Management. He holds an M.B.A. in Pharmaceutical Management, M.S. in Biotechnology, and a B.S. in Chemistry.

Grant is the founder of Smarter and Safer Products, a Niche consulting company focused on making products both smarter and safer through digital enablement. Clients include brand owners, solution providers, NGOs and other consultancies. Prior to this he spent 24 years working in the Healthcare Industry for GlaxoSmithKline in both manufacturing, supply chain and commercial positions. He has working closely with the European Commission, European Medicines Verification Organisation (EMVO), GS1 and other industry associations such as EFPIA, where he has been a trusted advisor in defining the industry’s advocacy and strategic approach to anti-counterfeiting and product traceability in Europe. He was an elected member of the GS1 Global Healthcare Leadership Team for ten years, developing the organisations strategy for driving adoption of standards to increase patient safety and lower healthcare costs globally. During this time, he also held the role of co-chair of the GS1 Healthcare Public Policy group which provided advocacy and advised regulators and authorities on how to implement Global Standards. Most recently he was one of the chairs of GS1’s Digital Link Standard Development teams, working on new standards aimed at web-enabling products. He has also been recognised through several industry awards including the Institute for Safe Medication Practices Award for preventing the spread of counterfeits in Nigeria and the Best Pharmacy Initiative - Falsified Medicines Directive anti-counterfeiting model. When not working Grant is a musician and DJ having performed internationally.

Scott Dubin is a Supply Chain, Private Sector Engagement Specialist with The Global Fund, where he creates innovative logistical solutions to ensure the uninterrupted supply of vital health supplies around the world. With a consistent focus in logistics, Scott has over 18 years of experience designing, implementing and managing humanitarian, development and diplomatic projects in a host of complex environments in the U.S. and abroad. In these roles he has worked on behalf of NGOs, private companies, and the U.S. government. Scott recently designed and lead a cutting edge initiative to utilize drone technology for delivering much-needed medicines, lab samples, blood transfusions and vaccines in Malawi. He has also developed a low cost, cloud based, transport management system, called TransIT, for use in low resource settings, which is now being transferred to open source software and becoming a global good. Scott holds a B.A. Business Administration and MSc. International business. He is married and a dad to two little girls.

Gregg is currently the US Serialisation Lead for GSK leading work on the US DSCSA saleable returns project and planning for GSK’s long term solution for the US DSCSA requirements in 2023. At GSK Gregg has held positions ranging from Analytics Reporting Manager in R&D Clinical Operations, Data Lead for the US SAP implementation, and Acting Director of Data Quality in the Transparency Data Operations & Reporting team in Pharma Finance. Prior to GSK, Gregg worked for 6 years at Pfizer in Global Logistics & Supply in the Global Enterprise Data Management group focused on SAP Material Master. Gregg has over 20 years of experience in multiple Leadership & Senior Data roles in the Pharmaceutical, Finance, and Software industries. Gregg holds an MBA in Management from Saint Joseph’s University’s Haub School of Business and a BS in Business Administration from Rider University. Gregg has a passion for data, systems, & business processes and strives to work towards solutions that benefit all

Kevin has over 28 years in the pharmaceutical and biopharmaceutical supply chain, distribution and transportation management world. His primary focus has been on operational and quality improvements while also maintaining or achieving additional cost savings through gained efficiencies. He has extensive experience setting up, qualifying, and overseeing the daily operations of in-house distribution centers & warehouses, as well as over 20 years of experience managing third party warehousing, transportation, cold-chain and contract manufacturing vendors and suppliers. He has managed distribution & logistics operations and vendors for both domestic and international customers & partners. Kevin has also qualified and implemented shipping lanes for all temperature ranges while using various active and passive solutions to meet all shipment size requirements from small parcel up to Sea Container. For relaxation Kevin enjoys traveling, taking walks on the beach with his wife, and occasionally dusting off his art supplies to draw or paint something that catches his interest. Kevin has worked for various manufacturers over the years and has lived in multiple regions of the country, most recently moving to the San Diego area to work with Gilead Biologics at their Oceanside, California site.

M. Dave Malenfant currently serves as Director of Outreach and Partnerships and oversees the Advisory Board for the Center for Supply Chain Innovation at Texas Christian University. Prior to this appointment, Dave served on the Advisory Board for the center from its inception in 2002. With a passion for talent development and career planning, Dave has helped develop the Executive Apprenticeship Program, judged the LINKS simulation game, and assisted students with internships and case competitions. Dave is also Executive Vice President of Industry Liaison and Talent Development for the BSMA (Biotech Supply Management Alliance) responsible for bringing best practices across the Biotech Industry. Prior to joining TCU, Dave spent over 35 years in a variety of industry roles. As an entrepreneur, Dave was Co-founder and President of Signature Consultants, Inc., (1973) a business, finance, and economic consulting firm that he ultimately sold in 1993. He created and operated a variety of other businesses that are still profitable in Canada today. In 1993, Dave joined Alcon Laboratories where he steadily advanced through leadership roles such as Purchasing Manager, Materials Operation Manager, and Global Supply Chain Director before becoming the Vice President of Global Supply Chain in 2005. In this role, Dave provided strategic direction for the company’s Global Supply Chain initiatives and created global centers of excellence for Purchasing, Distribution, Transportation, Customer Service, Sales and Operations Management, Data Management, Graphic Design and Artwork Development, and Product Launches. Dave retired from Alcon in 2014. Dave is recognized for the creative development of standardized systems and business processes, and for developing enabling technology throughout the entire supply chain. During his career, Dave has implemented over 30 different computer systems – WMS, ERP, Finite Scheduling, Product Launch, and Order Entry, among others. Dave serves on the Executive of the DFW CSCMP Roundtable and ISM-Fort Worth. He is past Chairman of the Supply Chain Council and past member of the Executive Committee of NASSTRAC. Given his vast knowledge of the end-to-end, integrated supply chain, Dave is a frequent speaker on Global Supply Chain Trends and Digitalization. He has consistently demonstrated his passion for Supply Chain management, developing talent, and the need to advance Supply Chain theory and innovation throughout a variety of industries.

Brett Marshall is the Vice President of Quality Assurance at Zuellig Pharma, one of the largest healthcare services groups in Asia with a mission of making healthcare more accessible. Based in Singapore, Brett has direct reporting lines from Quality Assurance Heads in 13 Countries and Quality oversight of Clinical Reach Operations in another 4 Countries. Brett is a strong advocate of change for the Quality landscape in Asia. He actively drives more effective risk management in the Cold Chain, Supplier Management and digitisation opportunities driving to Industry 4.0 in the Quality space. Originally from Melbourne, Australia, Brett has a Bachelor's Degree in Transport & Logistics Management from RMIT. He has 25 years’ experience in Executive Management, Logistics & Supply Chain, Business Process Transformation and Quality Assurance and 15 years in the Pharma Industry. He has spent more than 20 years living in Asia including Indonesia, Thailand, the Philippines, Bangladesh and now Singapore.

Michael Townsend is a Research Director for IDC Health Insights responsible for Commercial Life Sciences Strategies. He provides research-based advisory and consulting services, as well as market analysis on key topics within the commercial life science industry. Mr. Townsend's research expertise includes sales and marketing, supply chain, manufacturing systems, and emerging technologies and market trends. Mr. Townsend brings 20+ years of engineering and operational management experience at manufacturers serving the Life Sciences industry including Carl Zeiss, Ametek, and Danaher. He served as President and CEO of Dover Instrument Corporation prior to and including its merger with Danaher Corporation. He has been involved in the specification, design and operation of ERP and CRM systems in various management roles. Mr. Townsend holds a Bachelor of Science degree in Mechanical Engineering from the University of Connecticut and an MBA from the University of Connecticut including post-graduate work at Babson College.

Yingming Yue is currently the VP, Operations for Prinston Pharmaceutical. Prior to Prinston, he had held various leadership positions with Eddingpharm, Novartis, and Nektar Therapeutics. Early in his career, he was an operations consultant with Deloitte Consulting and Pittiglio Rabin Todd & McGrath (PRTM). Yingming is a senior supply chain leader with over twenty years experiences helping companies of various sizes establish world class business processes and improve operating efficacy. He specializes in the areas of operational improvement, supply chain planning, material management, lean manufacturing, risk management, and global ERP implementation. Yue received an MBA degree from the University of Chicago and MS in Applied Chemistry from Tianjin University. Yingming Yue is certified in Production and Inventory Management (CPIM) by APICS.